2-(tert-Butyl)imidazo[1,2-a]pyridine

Catalog No.: 
ACJSQV725
CAS No.: 
406207-65-6
Molecular Formula: 
C11H14N2
Molecular Weight: 
174.25
2-(tert-Butyl)imidazo[1,2-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$61.00In stockInquiry
250mg98%$102.00In stockInquiry
1g98%$384.00In stockInquiry
5g98%$1882.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(tert-Butyl)imidazo[1,2-a]pyridine
IUPAC Name2-(tert-butyl)imidazo[1,2-a]pyridine
MDL No.MFCD00269176
Molecular FormulaC11H14N2
Molecular Weight174.25
SMILESCC(C1=CN2C=CC=CC2=N1)(C)C
InChI KeyPGLHGXMDGUTQON-UHFFFAOYSA-N
SynonymBUTTPARK 7\05-91;2-TERT-BUTYL-IMIDAZO[1,2-A]PYRIDINE;Imidazo[1,2-a]pyridine, 2-(1,1-dimethylethyl)-;2-(1,1-Dimethylethyl)imidazo[1,2-a]pyridine
CAS No.406207-65-6
PubChem CID7141921

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJSQV725 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFHXR638 route compound structure diagram
    ACFHXR638109-04-6In Stock
  2. Plus
  3. ACQPFD254 route compound structure diagram
    ACQPFD25421149-98-4In Stock
  4. Then
  5. ACJSQV725 route product structure diagram
    ACJSQV725406207-65-6In Stock
Inquiry

2. ACJSQV725 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJSQV725 route product structure diagram
    ACJSQV725406207-65-6In Stock
Inquiry

3. ACJSQV725 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJSQV725 route product structure diagram
    ACJSQV725406207-65-6In Stock
Inquiry

Comments (0)